RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,820,348 | +52.6% | 384,748 | +9.8% | 0.00% | +50.0% |
Q2 2023 | $5,780,718 | +42.1% | 350,559 | +53.7% | 0.00% | +100.0% |
Q1 2023 | $4,068,180 | -39.2% | 228,037 | -0.8% | 0.00% | -50.0% |
Q4 2022 | $6,695,154 | +33.8% | 229,916 | +12.6% | 0.00% | 0.0% |
Q3 2022 | $5,005,000 | +598.0% | 204,269 | +18.3% | 0.00% | – |
Q2 2022 | $717,000 | -79.1% | 172,730 | -42.1% | 0.00% | -100.0% |
Q1 2022 | $3,437,000 | +19.1% | 298,325 | +3.2% | 0.00% | 0.0% |
Q4 2021 | $2,886,000 | -17.0% | 289,106 | +8.5% | 0.00% | 0.0% |
Q3 2021 | $3,479,000 | -33.6% | 266,362 | -0.5% | 0.00% | -50.0% |
Q2 2021 | $5,241,000 | -2.3% | 267,631 | +6.1% | 0.00% | 0.0% |
Q1 2021 | $5,365,000 | -13.6% | 252,222 | +20.8% | 0.00% | 0.0% |
Q4 2020 | $6,210,000 | +39.3% | 208,873 | +1.5% | 0.00% | 0.0% |
Q3 2020 | $4,459,000 | -4.8% | 205,741 | -2.1% | 0.00% | 0.0% |
Q2 2020 | $4,686,000 | +64.2% | 210,124 | +12.1% | 0.00% | 0.0% |
Q1 2020 | $2,853,000 | -32.3% | 187,421 | +2.1% | 0.00% | 0.0% |
Q4 2019 | $4,214,000 | +48.7% | 183,512 | +39.9% | 0.00% | 0.0% |
Q3 2019 | $2,833,000 | +0.3% | 131,216 | +2.2% | 0.00% | 0.0% |
Q2 2019 | $2,824,000 | -5.9% | 128,339 | +17.3% | 0.00% | 0.0% |
Q1 2019 | $3,000,000 | +6.8% | 109,422 | +4.7% | 0.00% | 0.0% |
Q4 2018 | $2,810,000 | -8.9% | 104,522 | -1.2% | 0.00% | 0.0% |
Q3 2018 | $3,086,000 | +107.4% | 105,793 | +122.3% | 0.00% | +100.0% |
Q2 2018 | $1,488,000 | +134.3% | 47,595 | +49.2% | 0.00% | – |
Q1 2018 | $635,000 | -29.8% | 31,900 | +2.6% | 0.00% | -100.0% |
Q4 2017 | $904,000 | – | 31,081 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |